Singular Genomics Systems (OMIC) Short Interest Ratio & Short Volume $19.80 +0.05 (+0.25%) As of 12:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Singular Genomics Systems Short Interest DataSingular Genomics Systems (OMIC) has a short interest of 45,400 shares, representing 2.95% of the float (the number of shares available for trading by the public). This marks a -8.65% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 10,813 shares to cover all short positions.Current Short Interest45,400 sharesPrevious Short Interest49,700 sharesChange Vs. Previous Month-8.65%Dollar Volume Sold Short$893,926.00Short Interest Ratio2.1 Days to CoverLast Record DateJanuary 15, 2025Outstanding Shares2,540,000 sharesFloat Size1,540,000 sharesShort Percent of Float2.95%Today's Trading Volume6,812 sharesAverage Trading Volume10,813 sharesToday's Volume Vs. Average63% Short Selling Singular Genomics Systems? Sign up to receive the latest short interest report for Singular Genomics Systems and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOMIC Short Interest Over TimeOMIC Days to Cover Over TimeOMIC Percentage of Float Shorted Over Time Singular Genomics Systems Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/202545,400 shares $893,926.00 -8.7%3.0%2.1 $19.69 12/31/202449,700 shares $965,671.00 -11.9%3.3%2.1 $19.43 12/15/202456,400 shares $1.13 million -7.8%3.7%1.8 $20.00 11/30/202461,200 shares $1.34 million -14.0%4.1%0.6 $21.90 11/15/202471,200 shares $1.56 million No Change4.7%0.7 $21.90 10/31/202471,200 shares $948,384.00 -18.9%4.8%0.7 $13.32 10/15/202487,800 shares $1.30 million -14.4%5.9%0.9 $14.84 9/30/2024102,600 shares $1.61 million -4.1%6.9%1.1 $15.67 9/15/2024107,000 shares $1.32 million +830.4%7.2%1.2 $12.38 8/31/202411,500 shares $81,738.55 -17.9%0.8%1.6 $7.11 Get the Latest News and Ratings for OMIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. 8/15/202414,000 shares $100,604.00 -0.7%0.9%2.3 $7.19 7/31/202414,100 shares $117,030.00 +13.7%1.0%2.4 $8.30 7/15/202412,400 shares $103,912.00 -17.9%0.9%2.2 $8.38 6/30/202415,100 shares $127,595.00 +109.7%1.1%2.6 $8.45 6/15/20247,200 shares $69,120.00 -97.0%0.0%1.5 $9.60 5/31/2024240,000 shares $87,528.00 -42.1%0.6%1.9 $0.36 5/15/2024414,400 shares $157,472.00 -37.9%1.0%3.3 $0.38 4/30/2024667,200 shares $267,547.20 +10.6%1.6%5.7 $0.40 4/15/2024603,300 shares $227,444.10 -17.6%1.4%5.3 $0.38 3/31/2024732,300 shares $376,548.66 -10.0%1.7%7.1 $0.51 3/15/2024813,500 shares $406,750.00 +7.3%1.9%6.5 $0.50 2/29/2024757,900 shares $432,003.00 -7.5%1.8%5.1 $0.57 2/15/2024819,000 shares $449,631.00 -5.9%2.0%4.9 $0.55 1/31/2024870,200 shares $439,451.00 -4.5%2.1%1.5 $0.51 1/15/2024911,200 shares $396,372.00 -17.2%2.2%1.6 $0.44 12/31/20231,100,000 shares $506,110.00 -5.2%2.6%1.9 $0.46 12/15/20231,160,000 shares $492,652.00 +3.6%2.8%2 $0.42 11/30/20231,120,000 shares $438,816.00 -27.3%2.7%1.9 $0.39 11/15/20231,540,000 shares $608,300.00 +40.0%3.7%2.6 $0.40 10/31/20231,100,000 shares $365,750.00 +8.9%2.7%2.3 $0.33 10/15/20231,010,000 shares $379,255.00 +3.4%2.5%4.2 $0.38 9/30/2023977,300 shares $372,351.30 +1.2%2.4%4.3 $0.38 9/15/2023965,800 shares $404,766.78 -3.3%2.4%3 $0.42 8/31/2023998,600 shares $469,242.14 +5.2%2.1%3.2 $0.47 8/15/2023949,400 shares $508,403.70 +1.7%2.0%3 $0.54 7/31/2023933,600 shares $740,251.44 +3.0%2.1%3.1 $0.79 7/15/2023906,200 shares $821,379.68 -0.1%2.0%3.2 $0.91 6/30/2023907,500 shares $753,225.00 -62.8%2.0%3.1 $0.83 6/15/20232,440,000 shares $2.08 million +10.9%5.5%8.3 $0.85 5/31/20232,200,000 shares $2.32 million +0.9%4.9%11.3 $1.06The Shadow President? (Ad)President Trump has already launched a "shock and awe" flurry of new Executive Orders... He's withdrawn from the World Health Organization... exited the Paris climate accord... and begun dismantling many Federal programs... But there's ONE executive order that could go down in history as the most important of all.It's likely just the start of a MUCH more radical move. 5/15/20232,180,000 shares $1.95 million -0.9%4.9%12.1 $0.89 4/30/20232,200,000 shares $2.18 million +5.3%4.9%15 $0.99 4/15/20232,090,000 shares $2.15 million +3.0%4.7%14.8 $1.03 3/31/20232,030,000 shares $2.46 million +6.8%4.6%14.4 $1.21 3/15/20231,900,000 shares $2.43 million +8.6%4.3%14.1 $1.28 2/28/20231,750,000 shares $3.76 million -0.6%3.9%14.3 $2.15 2/15/20231,760,000 shares $4.24 million -10.2%4.0%15.3 $2.41 1/31/20231,960,000 shares $5.24 million -15.2%4.4%15.5 $2.68 1/15/20232,310,000 shares $4.87 million -3.4%5.3%17.1 $2.11 12/30/20222,390,000 shares $4.80 million -8.4%5.5%17 $2.01 12/15/20222,610,000 shares $5.87 million +1.6%6.4%15.6 $2.25 11/30/20222,570,000 shares $5.24 million -6.6%6.3%12.2 $2.04 11/15/20222,750,000 shares $6.57 million -2.8%7.7%12.1 $2.39 10/31/20222,830,000 shares $7.53 million -9.6%7.9%10.3 $2.66 10/15/20223,130,000 shares $7.26 million -2.8%8.8%11.4 $2.32 9/30/20223,220,000 shares $8.05 million +1.9%9.0%11.9 $2.50 9/15/20223,160,000 shares $10.59 million -3.4%8.9%10.2 $3.35 8/31/20223,270,000 shares $8.73 million +5.1%9.2%11.3 $2.67 8/15/20223,110,000 shares $13.40 million +12.3%8.4%8.8 $4.31 7/31/20222,770,000 shares $10.55 million -8.6%8.0%7.8 $3.81 7/15/20223,030,000 shares $12.54 million +3.8%8.7%7.8 $4.14 6/30/20222,920,000 shares $11.15 million +16.8%9.0%6.9 $3.82 6/15/20222,500,000 shares $7.53 million +0.4%7.7%5.9 $3.01 5/31/20222,490,000 shares $8.09 million -10.1%7.7%4.8 $3.25 5/15/20222,770,000 shares $9.14 million +15.4%8.6%4.9 $3.30 4/30/20222,400,000 shares $9.82 million +9.6%8.1%4.4 $4.09 4/15/20222,190,000 shares $10.77 million -20.7%7.2%4.1 $4.92 3/31/20222,760,000 shares $17.42 million +43.8%9.0%5.2 $6.31 3/15/20221,920,000 shares $12.48 million +8.5%6.3%3.7 $6.50 2/28/20221,770,000 shares $14.57 million +4.1%5.7%4.3 $8.23 2/15/20221,700,000 shares $13.21 million +7.6%5.5%4.6 $7.77 1/31/20221,580,000 shares $12.25 million +46.3%4.4%4.8 $7.75 1/15/20221,080,000 shares $8.38 million -6.1%3.0%3.7 $7.76 12/31/20211,150,000 shares $13.29 million +13.9%3.2%4.4 $11.56 12/15/20211,010,000 shares $11.89 million -21.1%2.8%4.1 $11.77 11/30/20211,280,000 shares $14.62 million +14.3%3.7%6.1 $11.42 11/15/20211,120,000 shares $16.68 million +17.4%3.2%5.9 $14.89 10/29/2021954,300 shares $13.22 million -2.5%2.8%6.2 $13.85 10/15/2021978,500 shares $13.72 million +12.5%2.8%7.3 $14.02 9/30/2021869,600 shares $9.73 million +27.0%2.5%6.1 $11.19 9/15/2021684,900 shares $9.53 million +3.0%2.0%4.6 $13.92 8/31/2021665,300 shares $10.99 million +13.5%1.9%5 $16.52 8/13/2021586,000 shares $8.92 million No Change1.7%2.3 $15.23 OMIC Short Interest - Frequently Asked Questions What is Singular Genomics Systems' current short interest? Short interest is the volume of Singular Genomics Systems shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 45,400 shares of OMIC short. 2.95% of Singular Genomics Systems' shares are currently sold short. Learn More on Singular Genomics Systems' current short interest. What is a good short interest ratio for Singular Genomics Systems? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMIC shares currently have a short interest ratio of 2.0. Learn More on Singular Genomics Systems's short interest ratio. What is a good short interest percentage for Singular Genomics Systems? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.95% of Singular Genomics Systems' floating shares are currently sold short. Is Singular Genomics Systems' short interest increasing or decreasing? Singular Genomics Systems saw a decrease in short interest in January. As of January 15th, there was short interest totaling 45,400 shares, a decrease of 8.7% from the previous total of 49,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Singular Genomics Systems' float size? Singular Genomics Systems currently has issued a total of 2,540,000 shares. Some of Singular Genomics Systems' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Singular Genomics Systems currently has a public float of 1,540,000 shares. How does Singular Genomics Systems' short interest compare to its competitors? 2.95% of Singular Genomics Systems' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Singular Genomics Systems: Kewaunee Scientific Co. (2.55%), Frequency Electronics, Inc. (0.37%), Akoya Biosciences, Inc. (4.38%), Seer, Inc. (4.95%), 908 Devices Inc. (7.55%), ClearSign Technologies Co. (0.48%), Syntec Optics Holdings, Inc. (2.34%), Owlet, Inc. (4.31%), Rapid Micro Biosystems, Inc. (0.55%), MultiSensor AI Holdings, Inc. (3.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Singular Genomics Systems stock? Short selling OMIC is an investing strategy that aims to generate trading profit from Singular Genomics Systems as its price is falling. OMIC shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Singular Genomics Systems? A short squeeze for Singular Genomics Systems occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OMIC, which in turn drives the price of the stock up even further. How often is Singular Genomics Systems' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMIC, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies Kewaunee Scientific Short Interest Data Frequency Electronics Short Interest Data Akoya Biosciences Short Interest Data Seer Short Interest Data 908 Devices Short Interest Data ClearSign Technologies Short Interest Data Syntec Optics Short Interest Data Owlet Short Interest Data Rapid Micro Biosystems Short Interest Data MultiSensor AI Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OMIC) was last updated on 1/30/2025 by MarketBeat.com Staff From Our Partners#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredHot Stock Alert! Biotech innovator on the NYSE announces breakthrough antiviral therapyA revolutionary antiviral drug is here! This breakthrough could mean viruses are unlikely to escape treatment....Smallcaps Daily | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Singular Genomics Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Singular Genomics Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.